Evercyte GmbH

Evercyte GmbH is an SME in Wien, Austria that has taken part in 8 EU-funded projects since 2009, receiving €2.3M in EU funding.

EU funding received€2.3M
EU projects8
As coordinator0
Running now0
First EU project2009
Latest project2022
CountryAustria
EU registration (PIC)961596406
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Evercyte GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.4M · 4 projects
  • Horizon 2020€684k · 3 projects
  • Horizon Europe€270k · 1 project

Projects

8 EU-funded projects, newest first. Each links to the official record.

  • CHANGEPartner

    Cellular Homeostasis ANd AGing in Connective TissuE Disorders

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €270ktheir share
  • LIFESAVERPartner

    Living Impact on Fetal Evolution: Shelter-Analyze-Validate-Empower Regulations

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €428ktheir share
  • in3Partner

    An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €256ktheir share
  • eCHO SystemsPartner

    Enhancing CHO by Mammalian Systems Biotechnology (eCHO systems)

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • SYBILPartner

    Systems biology for the functional validation of genetic determinants of skeletal diseases

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €431ktheir share
  • FRAILOMICPartner

    Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €592ktheir share
  • NANOCARDPartner

    Nanopatterned scaffolds for active myocardial implants

    FP7 (2007 to 2013) · 2010–2013 · Project on CORDIS ↗

    €178ktheir share
  • NANOIIPartner

    Nanoscopically-guided induction and expansion of regulatory hematopoietic cells to treat autoimmune and inflammatory processes

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €178ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • autoimmune diseases
  • biomolecules
  • cardiovascular diseases
  • cell biology
  • cells technologies
  • diabetes
  • embryology
  • fetal medicine
  • genomes
  • homeostasis
  • implants
  • mathematical model
  • medicinal chemistry
  • microfluidics

Evercyte GmbH is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime